Skip to main content
91°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about MRK
Recent news which mentions MRK
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
October 21, 2024
Tickers
GILD
MRK
NEWS
Tags
Biotech
Briefs
Large Cap
From
Benzinga
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
October 18, 2024
Tickers
GILD
MRK
NEWS
Tags
Market News
News
FDA
From
Benzinga
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
October 18, 2024
Tickers
BIOVF
MRK
NEWS
Tags
News
Market News
pharmacy
From
Benzinga
Up 700% This Year, Is It Too Late to Invest in This Stock?
October 15, 2024
Tickers
MRK
SMMT
Tags
Recent Press Releases
Market News
MRK
From
Motley Fool
2 Incredibly Cheap Big Pharma Stocks to Buy Now
October 12, 2024
Tickers
MRK
PFE
Tags
Recent Press Releases
PFE
Market News
From
Motley Fool
A Closer Look at Merck & Co's Options Market Dynamics
October 11, 2024
Tickers
MRK
Tags
BZI/UOA
Market News
Markets
From
Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
October 10, 2024
Tickers
ADT
AMGN
AVGO
AZEK
Tags
UPST
C
SYF
From
Benzinga
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
October 10, 2024
Tickers
MRK
MRNA
MYNZ
PFE
Tags
contributors
Market News
MRNA
From
Benzinga
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
October 09, 2024
Tickers
ALMS
MRK
NEWS
PEP
Tags
U
Long Ideas
SOUN
From
Benzinga
Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
October 08, 2024
Tickers
GSK
MRK
NEWS
Tags
Top Stories
Stories That Matter
Legal
From
Benzinga
Merck Touts Phase 3 Success For $20B Cancer Drug Keytruda In Untreated Head And Neck Cancer Patients
October 08, 2024
Tickers
MRK
Tags
Health Care
Market News
Benzinga
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Tickers
BMY
ELV
HIMS
HUM
Tags
HIMS
SAVA
MRNA
From
Benzinga
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
October 07, 2024
Tickers
MRK
SMMT
VKTX
Tags
Recent Press Releases
VKTX
Market News
From
Motley Fool
Is It Time to Buy September's Worst-Performing Dow Jones Stocks?
October 05, 2024
Tickers
BA
DJI
JPM
MRK
Tags
JPM
BA
MRK
From
Motley Fool
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Tickers
AZN
MRK
NEWS
NVO
Tags
Large Cap
Benzinga
NVO
From
Benzinga
Could Summit Therapeutics Become the Next Merck?
October 04, 2024
Tickers
MRK
SMMT
Tags
Market News
Recent Press Releases
SMMT
From
Motley Fool
Demystifying Merck & Co: Insights From 8 Analyst Reviews
October 03, 2024
Tickers
MRK
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
October 03, 2024
Tickers
MRK
NEWS
Tags
News
Trading Ideas
Market News
From
Benzinga
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
Tickers
MRK
MRNA
MYNZ
PFE
Tags
PFE
Market News
contributors
From
Benzinga
2 High-Potential Growth Stocks You Shouldn't Overlook
September 29, 2024
Tickers
LUNR
MRK
SMMT
Tags
MRK
SMMT
Recent Press Releases
From
Motley Fool
Is Merck Stock a Buy?
September 29, 2024
Tickers
MRK
Tags
MRK
Market News
Recent Press Releases
From
Motley Fool
Evaxion Biotech Partners With Merck To Expand Vaccine Development
September 26, 2024
Tickers
EVAX
MRK
NEWS
Tags
Trading Ideas
Movers
Health Care
From
Benzinga
This Is What Whales Are Betting On Merck & Co
September 25, 2024
Tickers
MRK
Tags
Markets
Options
MRK
From
Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Tickers
BGNE
BMY
MRK
NEWS
Tags
Health Care
Benzinga
Large Cap
From
Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Tickers
LLY
MRK
NEWS
Tags
Health Care
LLY
pharmaceuticals
From
Benzinga
Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study
September 25, 2024
Tickers
MRK
NEWS
Tags
Market News
News
General
From
Benzinga
Merck & Co Unusual Options Activity For September 23
September 23, 2024
Tickers
MRK
Tags
Market News
BZI/UOA
Benzinga
From
Benzinga
Pfizer Advances On Its Cancer Journey
September 20, 2024
Tickers
MRK
MRNA
MYNZ
PFE
Tags
General
MYNZ
MRK
From
Benzinga
Is It Too Late to Buy ServiceNow Stock?
September 20, 2024
Tickers
IT
MRK
NOW
STLA
Tags
Market News
IT
STLA
From
Motley Fool
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer
September 18, 2024
Tickers
MRK
NEWS
Tags
General
Stories That Matter
Top Stories
From
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.